Scientists with the Fralin Biomedical Research Institute at VTC have created an engineered model of the supportive tissue found within a lymph node to study human health.
New research from SUNY Polytechnic Institute introduces an innovative, eco-friendly method to enhance the performance and longevity of titanium-based dental implants, focusing on improving the biocompatibility and mechanical resilience of Ti-6Al-4V alloy implants using hydroxyapatite (HA) coatings derived from biowaste.
A study published in Current Biology demonstrates that scientists can identify individuals based solely on their breathing patterns with 96.8% accuracy. These nasal respiratory “fingerprints” also offer insights into physical and mental health.
Researchers from Tel Aviv University and Sheba Tel Hashomer Medical Center have developed an innovative bioengineered skin equivalent for grafting in burn victims. The bioengineered skin produced from the patient’s own cells is more stable, robust, and flexible than current treatments, making it easier to handle.
A medical research team at Saarland University, led by Professor Bergita Ganse, has discovered a new approach to monitoring bone fracture healing by measuring blood supply to the tissue at the fracture site and the level of oxygen in the blood. Bone regeneration can be monitored quickly and easily using near-infrared light rather than harmful shorter wavelength radiation.
Each year, millions of people in the U.S. get dental implants as a long-term, natural-looking fix for missing teeth. But traditional implants don’t fully mimic real teeth.
Researchers at the University of California, Davis, have developed an investigational brain-computer interface that holds promise for restoring the voices of people who have lost the ability to speak due to neurological conditions.
IceCure has 20+ patents in the U.S. and the Company anticipates further market traction upon FDA’s marketing authorization decision in early-stage breast cancer
A team led by Rutgers University-New Brunswick engineers has developed a portable device capable of detecting rare genetic mutations from a single drop of blood.
A new study led by Keck Medicine of USC researchers may have uncovered an effective combination therapy for glioblastoma, a brain tumor diagnosis with few available effective treatments. According to the National Brain Tumor Society, the average survival for patients diagnosed with glioblastoma is eight months.